Replies to post #1056 on CardioVascular BioTherapeutics (fka CVBT)

[walhall]

It's great news that investors in Asia are reportedly interested in CVBT! As a shareholder, having CVBT funded will be something to celebrate.

My greatest hope however is that Asian investors will not be disturbed by the allegations of Mr. Wallen's alleged theft of $14 million from his last company and his upcoming fraud trial brought by the U.S. government Bankruptcy Trustee. I've never dealt with Asian investors before, but I'm hoping this won't bother Asian investors the way it may bother U.S. and European investors.

Here's more information about the upcoming fraud trial of CVBT's CEO, Calvin Wallen III:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150365915